Istituto Biostrutture e Bioimmagini, CNR, Viale A. Doria 6, Catania, Italy
Dipartimento di Scienze Chimiche, Università di Catania, Viale Andrea Doria 6, 95125, Catania, Italy
References: Phillips, L.K., Horowitz, M., IAPP (2006) Curr. Opin. Endocrinol. Diab., 13, p. 19
Cao, P., Abedini, A., Raleigh, D.P., Aggregation of islet amyloid polypeptide: From physical chemistry to cell biology (2013) Curr. Opin. Struct. Biol., 23, p. 82
Westermark, P., Andersson, A., Westermark, G.T., Islet amyloid polypeptide, islet amyloid and diabetes mellitus (2011) Physiol. Rev., 91, p. 795
Westermark, P., Engström, U., Johnson, K.H., Westermark, G.T., Betsholtz, C., Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation (1990) Proc. Natl. Acad. Sci. U. S. A., 87, p. 5036
Konarkowska, B., Aitken, J.F., Kistler, J., Zhang, S., Cooper, G.J., The aggregation potential of human IAPP determines its cytotoxicity towards islet beta-cells (2006) FEBS J., 273, p. 3614
Dupuis, N.F., Wu, C., Shea, J.-E., Bowers, M.T., The amyloid formation mechanism in human IAPP: Dimers have β-strand monomer-monomer interfaces (2011) J. Am. Chem. Soc., 133, p. 7240
Sedman, V.L., Allen, S., Chan, W.C., Davies, M.C., Roberts, C.J., Tendler, S.J., Williams, P.M., Atomic force microscopy study of human IAPP (20-29) fibrils (2005) Protein Peptide Lett., 12, p. 79
Pappalardo, G., Milardi, D., Magrì, A., Attanasio, F., Impellizzeri, G., La Rosa, C., Grasso, D., Rizzarelli, E., Environmental factors differently affect human and rat IAPP: Conformational preferences and membrane interactions of IAPP17-29 peptide derivatives (2007) Chemistry, 13, p. 10204
Jha, S., Patil, S.M., Gibson, J., Nelson, C.E., Alder, N.N., Alexandrescu, A.T., Mechanism of IAPP fibrillization enhancement by heparin (2011) J. Biol. Chem., 286, p. 22894
Mirhashemi, S.M., Aarabi, M.-H., Effect of two herbal polyphenol compounds on human IAPP amyloid formation and destabilization (2012) J. Med. Plants Res., 6, p. 3207
Chien, V., Aitken, J.F., Zhang, S., Buchanan, C.M., Hickey, A., Brittain, T., Cooper, G.J.S., Loomes, K.M., The chaperone proteins HSP70, HSP40/DnaJ and GRP78/BiP suppress misfolding and formation of β-sheet-containing aggregates by human IAPP: A potential role for defective chaperone biology in Type 2 diabetes (2010) Biochem. J., 432, p. 113
Cheng, B., Gong, H., Li, X., Sun, Y., Zhang, X., Chen, H., Liu, X., Huang, K., Silibinin inhibits the toxic aggregation of human islet amyloid polypeptide (2012) Biochem. Bioph. Res. Comm., 419, p. 495
Tu, L.-H., Raleigh, D.P., Role of aromatic interactions in amyloid formation by islet amyloid polypeptide (2013) Biochemistry, 52, p. 333
Kamihira-Ishijima, M., Nakazawa, H., Kira, A., Naito, A., Nakayama, T., Inhibitory mechanism of pancreatic amyloid fibril formation: Formation of the complex between tea catechins and the fragment of residues 22-27 (2012) Biochemistry, 51, p. 10167
Cao, P., Raleigh, D.P., Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols (2012) Biochemistry, 51, p. 2670
Cheng, B., Liu, X., Gong, H., Huang, L., Chen, H., Zhang, X., Li, C., Huang, K., Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: Possible link between coffee consumption and diabetes mellitus (2011) J. Agr. Food Chem., 59, p. 13147
Brender, J.R., Hartman, K., Nanga, R.P., Popovych, N., De La Salud Bea, R., Vivekanandan, S., Marsh, E.N., Ramamoorthy, A., Role of zinc in human islet amyloid polypeptide aggregation (2010) J. Am. Chem. Soc., 132, p. 8973
Lemaire, K., Ravier, M.A., Schraenen, A., Creemers, J.W.M., Van De Plas, R., Granvik, M., Van Lommel, L., Schuit, F.C., Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice (2009) Proc. Natl. Acad. Sci. U. S. A., 106, p. 14872
Masad, A., Hayes, L., Tabner, B.J., Turnbull, S., Cooper, L.J., Fullwood, N.J., German, M.J., Allsop, D., Copper-mediated formation of hydrogen peroxide from the IAPP peptide: A novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? (2007) FEBS Lett., 581, p. 3489
House, C.E.E., Patel, T., Wu, L., Fraser, P.E., Human pro-islet amyloid polypeptide (ProIAPP1-48) forms amyloid fibrils and amyloid spherulites in vitro (2010) J. Inorg. Biochem., 104, p. 1125
Ward, B., Walker, K., Exley, C., Copper(II) inhibits the formation of IAPP amyloid in vitro (2008) J. Inorg. Biochem., 102, pp. 371-375
Lee, E.C., Ha, E., Singh, S., Legesse, L., Ahmad, S., Karnaukhova, E., Donaldson, R.P., Jeremic, A.M., Copper(II)-human amylin complex protects pancreatic cells from amylin toxicity (2013) Phys. Chem. Chem. Phys., 15, p. 12558
Yu, Y.-P., Lei, P., Hu, J., Wu, W.-H., Zhao, Y.-F., Li, Y.-M., Copper-induced cytotoxicity: Reactive oxygen species or islet amyloid polypeptide oligomer formation (2010) Chem. Commun., 46, p. 6909
Kállay, C., Dávid, Á., Timári, S., Nagy, E.M., Sanna, D., Garribba, E., Micera, G., Sõvágõ, I., Copper(II) complexes of rat IAPP fragments (2011) Dalton Trans., 40, p. 9711
Kim, M.-J., Kim, H.-T., Investigation of the copper binding site on the human islet amyloid polypeptide hormone (2012) Eur. J. Mass Spectrom., 18, p. 51
Bennett, R.G., Duckworth, W.C., Hamel, F.G., Degradation of IAPP by insulin-degrading enzyme (2000) J. Biol. Chem., 275, p. 36621
Guan, H., Chow, K.M., Shah, R., Rhodes, C.J., Hersh, L.B., Degradation of islet amyloid polypeptide by neprilysin (2012) Diabetologia, 55, p. 2989
Aston-Mourney, K., Zraika, S., Udayasankar, J., Subramanian, S.L., Green, P.S., Kahn, S.E., Hull, R.L., Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide (2013) J. Biol. Chem., 288, p. 3553
Zraika, S., Aston-Mourney, K., Marek, P., Hull, R.L., Green, P.S., Udayasankar, J., Subramanian, S.L., Kahn, S.E., Neprilysin impedes islet amyloid formation by inhibition of fibril formation rather than peptide degradation (2010) J. Biol. Chem., 285, p. 18177
Bennett, R.G., Hamel, F.G., Duckworth, W.C., An insulin-degrading enzyme inhibitor decreases IAPP degradation, increases IAPP-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures (2003) Diabetes, 52, p. 2315
Ralat, L.A., Kalas, V., Zheng, Z.-Z., Goldman, R.D., Sosnick, T.R., Tang, W.-J., Ubiquitin is a novel substrate for human insulin-degrading enzyme (2011) J. Mol. Biol., 406, p. 454
Bellia, F., Pietropaolo, A., Grasso, G., Formation of insulin fragments by insulin-degrading enzyme: The role of zinc(II) and cystine bridges (2013) J. Mass Spectrom., 48, p. 135
Grasso, G., Rizzarelli, E., Spoto, G., How the binding and degrading capabilities of insulin degrading enzyme are affected by ubiquitin (2008) BBA-Protein Proteom., 1784, p. 1122
Malgieri, G., Grasso, G., The clearance of misfolded proteins in neurodegenerative diseases by zinc metalloproteases: An inorganic perspective (2014) Coordin. Chem. Rev., 260, p. 139
Ciaccio, C., Tundo, G.F., Grasso, G., Spoto, G., Marasco, D., Ruvo, M., Gioia, M., Coletta, M., Somatostatin: A novel substrate and a modulator of insulin degrading enzyme activity (2009) J. Mol. Biol., 385, p. 1556
Shen, Y., Joachimiak, A., Rosner, M.R., Tang, W.-J., Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism (2006) Nature, 443, p. 870
Guo, Q., Manolopoulou, M., Bian, Y., Schilling, A.B., Tang, W.-J., Molecular basis for the recognition and cleavages of IGF-II, TGF-α, and IAPP by human insulin-degrading enzyme (2010) J. Mol. Biol., 395, p. 430
Grasso, G., Salomone, F., Tundo, G.R., Pappalardo, G., Ciaccio, C., Spoto, G., Pietropaolo, A., Rizzarelli, E., Metal ions affect insulin-degrading enzyme activity (2012) J. Inorg. Biochem., 117, p. 351
Grasso, G., Giuffrida, M.L., Rizzarelli, E., Metal ions and proteolytic enzymes in Alzheimer's Disease (2012) Metallomics, 4, p. 937
Grasso, G., Pietropaolo, A., Spoto, G., Pappalardo, G., Tundo, G.R., Ciaccio, C., Coletta, M., Rizzarelli, E., Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: Implications for metallostasis alteration in Alzheimer's disease (2011) Chem.-Eur. J., 17, p. 2752
Autelitano, D.J., Rajic, A., Smith, A.I., Berndt, M.C., Ilag, L.L., Vadas, M., The cryptome: A subset of the proteome, comprising cryptic peptides with distinct bioactivities (2006) Drug Discov. Today, 11, p. 306
Duckworth, W.C., Fawcett, J., Tsui, B.T., Bennett, R.G., Hamel, F.G., Biological activity of a fragment of insulin (2004) Biochem. Biophys. Res. Comm., 318, p. 1019
Pimenta, D.C., Lebrun, I., Cryptides: Buried secrets in proteins (2007) Peptides, 28, p. 2403
Williams, N.R., Rajput-Williams, J., West, J.A., Nigdikar, S.V., Foote, J.W., Howard, A.N., Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus (1995) Analyst, 120, p. 887
Krebs, M.R., Bromley, E.H., Donald, A.M., The binding of thioflavin-T to amyloid fibrils: Localisation and implications (2005) J. Struct. Biol., 149, p. 30
Maezawa, I., Hong, H.S., Liu, R., Wu, C.Y., Cheng, R.H., Kung, M.P., Kung, H.F., Jin, L.W., Congo red and thioflavin-T analogs detect Abeta oligomers (2008) J. Neurochem., 104, p. 457
Hull, R.L., Westermark, G.T., Westermark, P., Kahn, S.E., Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes (2004) J. Clin. Endocr. Metab., 89, p. 3629
Gell, D.A., Grant, R.P., MacKay, J.P., The detection and quantitation of protein oligomerization (2012) Adv. Exp. Med. Biol., 747, p. 19
Grasso, G., The use of mass spectrometry to study amyloid-β peptides (2011) Mass Spectrom. Rev., 30, p. 347
Young, L., Ndlovu, H., Knapman, T.W., Harris, S.A., Radford, S.E., Ashcroft, A.E., Monitoring oligomer formation from self-aggregating amylin peptides using ESI-IMS-MS (2013) Int. J. Ion Mobil. Spec., 16, p. 29
Kloniecki, M., Jablonowska, A., Poznanski, J., Langridge, J., Hughes, C., Campuzano, I., Giles, K., Dadlez, M., Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers (2011) J. Mol. Biol., 407, p. 110
Cernescu, M., Stark, T., Kalden, E., Kurz, C., Leuner, K., Deller, T., Goebel, M., Brutschy, B., Laser-induced liquid bead ion desorption mass spectrometry: An approach to precisely monitor the oligomerization of the β-amyloid peptide (2012) Anal. Chem., 84, p. 5276
Liang, G., Zhao, J., Yu, X., Zheng, J., Comparative molecular dynamics study of human islet amyloid polypeptide (IAPP) and rat IAPP oligomers (2013) Biochemistry, 52, p. 1089
Singh, S., De Pablo, J.J., Effect of proline mutations on the monomer conformations of amylin (2013) Biophys. J., 105, p. 1227
Cech, N.B., Krone, J.R., Enke, C.G., Predicting electrospray response from chromatographic retention time (2001) Anal. Chem., 73, p. 208
Salamekh, S., Brender, J.R., Hyung, S.-J., Prakash, R., Nanga, R., Vivekanandan, S., Ruotolo, B.T., Ramamoorthy, A., A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc (2011) J. Mol. Biol., 410, p. 294
Goldsbury, C., Goldie, K., Pellaud, J., Seelig, J., Frey, P., Muller, S.A., Kistler, J., Aebi, U., Amyloid fibril formation from full-length and fragments of amylin (2000) J. Struct. Biol., 130, p. 352
Jansen, J., Karges, W., Rink, L., Zinc and diabetes - Clinical links and molecular mechanisms (2009) J. Nutr. Biochem., 20, p. 399
Viktorinova, A., Toserova, E., Krizko, M., Durackova, Z., Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus (2009) Metabolism, 58, p. 1477
Phillips, L. K., Horowitz, M., IAPP (2006) Curr. Opin. Endocrinol. Diab., 13, p. 19
Dupuis, N. F., Wu, C., Shea, J. -E., Bowers, M. T., The amyloid formation mechanism in human IAPP: Dimers have -strand monomer-monomer interfaces (2011) J. Am. Chem. Soc., 133, p. 7240
Sedman, V. L., Allen, S., Chan, W. C., Davies, M. C., Roberts, C. J., Tendler, S. J., Williams, P. M., Atomic force microscopy study of human IAPP (20-29) fibrils (2005) Protein Peptide Lett., 12, p. 79
Jha, S., Patil, S. M., Gibson, J., Nelson, C. E., Alder, N. N., Alexandrescu, A. T., Mechanism of IAPP fibrillization enhancement by heparin (2011) J. Biol. Chem., 286, p. 22894
Mirhashemi, S. M., Aarabi, M. -H., Effect of two herbal polyphenol compounds on human IAPP amyloid formation and destabilization (2012) J. Med. Plants Res., 6, p. 3207
Tu, L. -H., Raleigh, D. P., Role of aromatic interactions in amyloid formation by islet amyloid polypeptide (2013) Biochemistry, 52, p. 333
Brender, J. R., Hartman, K., Nanga, R. P., Popovych, N., De La Salud Bea, R., Vivekanandan, S., Marsh, E. N., Ramamoorthy, A., Role of zinc in human islet amyloid polypeptide aggregation (2010) J. Am. Chem. Soc., 132, p. 8973
House, C. E. E., Patel, T., Wu, L., Fraser, P. E., Human pro-islet amyloid polypeptide (ProIAPP1-48) forms amyloid fibrils and amyloid spherulites in vitro (2010) J. Inorg. Biochem., 104, p. 1125
Lee, E. C., Ha, E., Singh, S., Legesse, L., Ahmad, S., Karnaukhova, E., Donaldson, R. P., Jeremic, A. M., Copper (II) -human amylin complex protects pancreatic cells from amylin toxicity (2013) Phys. Chem. Chem. Phys., 15, p. 12558
Yu, Y. -P., Lei, P., Hu, J., Wu, W. -H., Zhao, Y. -F., Li, Y. -M., Copper-induced cytotoxicity: Reactive oxygen species or islet amyloid polypeptide oligomer formation (2010) Chem. Commun., 46, p. 6909
K llay, C., D vid, ., Tim ri, S., Nagy, E. M., Sanna, D., Garribba, E., Micera, G., S v g, I., Copper (II) complexes of rat IAPP fragments (2011) Dalton Trans., 40, p. 9711
Kim, M. -J., Kim, H. -T., Investigation of the copper binding site on the human islet amyloid polypeptide hormone (2012) Eur. J. Mass Spectrom., 18, p. 51
Bennett, R. G., Duckworth, W. C., Hamel, F. G., Degradation of IAPP by insulin-degrading enzyme (2000) J. Biol. Chem., 275, p. 36621
Guan, H., Chow, K. M., Shah, R., Rhodes, C. J., Hersh, L. B., Degradation of islet amyloid polypeptide by neprilysin (2012) Diabetologia, 55, p. 2989
Bennett, R. G., Hamel, F. G., Duckworth, W. C., An insulin-degrading enzyme inhibitor decreases IAPP degradation, increases IAPP-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures (2003) Diabetes, 52, p. 2315
Ralat, L. A., Kalas, V., Zheng, Z. -Z., Goldman, R. D., Sosnick, T. R., Tang, W. -J., Ubiquitin is a novel substrate for human insulin-degrading enzyme (2011) J. Mol. Biol., 406, p. 454
Autelitano, D. J., Rajic, A., Smith, A. I., Berndt, M. C., Ilag, L. L., Vadas, M., The cryptome: A subset of the proteome, comprising cryptic peptides with distinct bioactivities (2006) Drug Discov. Today, 11, p. 306
Duckworth, W. C., Fawcett, J., Tsui, B. T., Bennett, R. G., Hamel, F. G., Biological activity of a fragment of insulin (2004) Biochem. Biophys. Res. Comm., 318, p. 1019
Pimenta, D. C., Lebrun, I., Cryptides: Buried secrets in proteins (2007) Peptides, 28, p. 2403
Williams, N. R., Rajput-Williams, J., West, J. A., Nigdikar, S. V., Foote, J. W., Howard, A. N., Plasma, granulocyte and mononuclear cell copper and zinc in patients with diabetes mellitus (1995) Analyst, 120, p. 887
Krebs, M. R., Bromley, E. H., Donald, A. M., The binding of thioflavin-T to amyloid fibrils: Localisation and implications (2005) J. Struct. Biol., 149, p. 30
Hull, R. L., Westermark, G. T., Westermark, P., Kahn, S. E., Islet amyloid: A critical entity in the pathogenesis of type 2 diabetes (2004) J. Clin. Endocr. Metab., 89, p. 3629
Gell, D. A., Grant, R. P., MacKay, J. P., The detection and quantitation of protein oligomerization (2012) Adv. Exp. Med. Biol., 747, p. 19
Cech, N. B., Krone, J. R., Enke, C. G., Predicting electrospray response from chromatographic retention time (2001) Anal. Chem., 73, p. 208
The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme
Kállay C, Dávid A, Timári S, Nagy EM, Sanna D, Garribba E, Micera G, De Bona P, Pappalardo G, Rizzarelli E, Sóvágó I * Copper(II) complexes of rat amylin fragments(357 views) Dalton T (ISSN: 1477-9234, 1477-9226, 1477-9234electronic), 2011 Oct 14; 40(38): 9711-9721. Impact Factor:3.838 ViewExport to BibTeXExport to EndNote